CLINICAL UPDATES
from SpectraCell Laboratories, Inc.
February 2010 - Volume 4, Issue 02In this issue...
- Chromium supplementation enhances insulin sensitivity in diabetics
- High levels of CRP increase more than just heart disease risk
- Omega 3 fatty acids reduce risk of Alzhiemer's
- Omega 3 fatty acids can reduce risk of psychosis
- Telomere shortening in patients with heart disease may be reversible
- Vitamin deficiencies after gastric bypass common even with supplementation
In SpectraCell News...
- SpectraCell Enters into National Contract with Aetna. Read more...
- Dr. Ron Grabowski Named Director of Clinical Nutrition and Education. Read more...
- SpectraCell introduces Apo E genotype testing and Omega-3 Index in March.
CLINICAL UPDATE - chromium supplementation enhances insulin sensitivity in diabetics
In type 2 diabetics, clinical response to the supplementation was significantly correlated to baseline insulin sensitivity so that the more elevated the fasting glucose levels at baseline, the more effective the chromium supplementation was in enhancing insulin sensitivity.
(Metabolism, December 2009)
LINK to ABSTRACT Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.
CLINICAL UPDATE - high levels of crp increase more than just heart disease risk
Records on over 160,000 people that did not have cardiovascular disease were reviewed. As CRP increased, so did the risk of heart disease, stroke, lung disease and death from several cancers.
(Lancet, December 2009)
LINK to ABSTRACT C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
CLINICAL UPDATE - omega 3 fatty acids reduce risk of Alzheimer's
The omega-3 compound ethyl-eicosapentaenoic acid (E-EPA) may improve memory and learning, and reduce the risk of Alzheimer’s disease, says a new study.
(Journal of Neurochemistry, February 2010)
LINK to FULL STORY
LINK to ABSTRACT Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment.
CLINICAL UPDATE - omega 3 fatty acids can reduce risk of psychosis
Supplements of omega-3-rich fish oil may reduce the likelihood of developing psychotic disorders in high-risk people, says results of a new clinical trial.
(Archives of General Psychiatry, January 2010)
LINK to FULL STORY
LINK to ABSTRACT Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
CLINICAL UPDATE - telomere shortening in patients with heart disease may be reversible
In a five year study of 608 people with stable coronary artery disease, 23% of the patients’ telomeres actually increased, while 32% of the patients’ telomeres maintained their length and the remaining 45% had telomeres that shortened during the study, indicating that telomere shortening in people with heart disease is potentially reversible like it is in healthy individuals.
(PLoS ONE, January 2010)
LINK to ABSTRACT Telomere Length Trajectory and Its Determinants in Persons with Coronary Artery Disease: Longitudinal Findings from the Heart and Soul Study.
LINK to FREE FULL TEXT
CLINICAL UPDATE - vitamin deficiencies after gastric bypass common even with supplementation
Researchers emphasize that even patients on multivitamins for life should be routinely and diligently monitored for vitamin deficiencies as they estimate 98% of gastric bypass patients will develop nutritional deficiencies post surgery.
(Southern Medical Journal, October 2009)
LINK to ABSTRACT Vitamin deficiency after gastric bypass surgery: a review.
LINK to FREE FULL TEXT
